Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kinnate Biopharma Inc. (KNTE) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kinnate Biopharma Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1797768.
Total stock buying since 2020: $79,805,041.
Total stock sales since 2020: $0.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 9,292,200 | $25,488,264 | 0 | $0 | 0 | $0 |
| 2022 | 431,400 | $4,316,777 | 0 | $0 | 0 | $0 |
| 2020 | 2,500,000 | $50,000,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-05 | 8,590,702 | $23,699,446 | 0 | $0 | 0 | $0 |
| 2023-04 | 701,498 | $1,788,818 | 0 | $0 | 0 | $0 |
| 2022-03 | 40,000 | $338,849 | 0 | $0 | 0 | $0 |
| 2022-02 | 391,400 | $3,977,928 | 0 | $0 | 0 | $0 |
| 2020-12 | 2,500,000 | $50,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-08 | Foresite Capital Opportunity Management V, Llc (10% Owner) | Buy | 1,780,000 | 2.80 | 4,984,000 |
| 2023-05-08 | Tananbaum James B. (Director) | Buy | 1,780,000 | 2.80 | 4,984,000 |
| 2023-05-05 | Gordon Carl L | Buy | 981,023 | 2.82 | 2,766,484 |
| 2023-05-05 | Orbimed Capital Llc | Buy | 981,023 | 2.82 | 2,766,484 |
| 2023-05-04 | Gordon Carl L | Buy | 479,909 | 2.75 | 1,319,749 |
| 2023-05-04 | Orbimed Capital Llc | Buy | 479,909 | 2.75 | 1,319,749 |
| 2023-05-02 | Gordon Carl L | Buy | 338,262 | 2.67 | 903,159 |
| 2023-05-02 | Orbimed Capital Llc | Buy | 338,262 | 2.67 | 903,159 |
| 2023-05-01 | Gordon Carl L | Buy | 716,157 | 2.62 | 1,876,331 |
| 2023-05-01 | Orbimed Capital Llc | Buy | 716,157 | 2.62 | 1,876,331 |
| 2023-04-28 | Gordon Carl L | Buy | 350,749 | 2.55 | 894,409 |
| 2023-04-28 | Orbimed Capital Llc | Buy | 350,749 | 2.55 | 894,409 |
| 2022-03-14 | Williams Richard Thomas (Chief Medical Officer) | Buy | 25,000 | 8.37 | 209,249 |
| 2022-03-11 | Williams Richard Thomas (Chief Medical Officer) | Buy | 15,000 | 8.64 | 129,600 |
| 2022-02-15 | Gordon Carl L | Buy | 9,000 | 9.96 | 89,640 |
| 2022-02-15 | Orbimed Capital Llc | Buy | 9,000 | 9.96 | 89,640 |
| 2022-02-14 | Gordon Carl L | Buy | 30,700 | 9.94 | 305,004 |
| 2022-02-14 | Orbimed Capital Llc | Buy | 30,700 | 9.94 | 305,004 |
| 2022-02-11 | Gordon Carl L | Buy | 156,000 | 10.22 | 1,594,320 |
| 2022-02-11 | Orbimed Capital Llc | Buy | 156,000 | 10.22 | 1,594,320 |
| 2020-12-03 | Tananbaum James B. | Buy | 1,000,000 | 20.00 | 20,000,000 |
| 2020-12-02 | Gordon Carl L | Buy | 750,000 | 20.00 | 15,000,000 |
| 2020-12-02 | Orbimed Capital Llc | Buy | 750,000 | 20.00 | 15,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of KNTE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kinnate Biopharma Inc. (symbol KNTE, CIK number 1797768) see the Securities and Exchange Commission (SEC) website.